10-Q · 2026-11-13
Verrica Pharmaceuticals unveils its Q3 financial results, highlighting developments in operations and their impact on the pharmaceutical industry.
| Name | Verrica Pharmaceuticals Inc. |
|---|---|
| CIK | 0001660334 |
| Tickers | VRCA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 463137900 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 484-453-3300 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Verrica Pharmaceuticals unveils its Q3 financial results, highlighting developments in operations and their impact on the pharmaceutical industry.
Verrica Pharmaceuticals announces strong Q3 2026 results, highlighting record revenue and ongoing clinical advancements in its product pipeline.
538 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001943462-26-000009 | 005-90530 | 261556658 | 34 | 74131 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000698 | 005-90530 | 261552854 | 34 | 10868 | |||
| 2026-11-13 | 10-Q | 10-Q | 0001660334-26-000030 | 001-38529 | 261549043 | 34 | 6760881 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-458527 | 001-38529 | 261547474 | 34 | 294417 | 1 | 1 |
| 2026-08-18 | 4 | xslF345X06/form4-08182026_050804.xml | 0002046750-26-000004 | 5270 | ||||||
| 2026-08-18 | 4 | xslF345X06/form4-08182026_050802.xml | 0002043558-26-000005 | 10018 | ||||||
| 2026-08-18 | 4 | xslF345X06/form4-08182026_050809.xml | 0001579649-26-000005 | 6764 | ||||||
| 2026-08-18 | 4 | xslF345X06/form4-08182026_050806.xml | 0001556327-26-000003 | 5235 | ||||||
| 2026-08-06 | 10-Q | 10-Q | 0001660334-26-000025 | 001-38529 | 261249864 | 34 | 40216406 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-338273 | 001-38529 | 261249803 | 34 | 304329 | 1 | 1 |
| 2026-06-09 | 4 | xslF345X06/form4-06092026_040606.xml | 0001814892-26-000002 | 5720 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_040603.xml | 0001814338-26-000002 | 5679 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_040601.xml | 0001257544-26-000002 | 5686 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_040614.xml | 0001579649-26-000002 | 6293 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_040612.xml | 0002046750-26-000002 | 6310 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_040610.xml | 0002043558-26-000002 | 6282 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_040608.xml | 0001745995-26-000002 | 5695 | ||||||
| 2026-06-09 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-263722 | 001-38529 | 261076076 | 34 | 325011 | 1 | 1 |
| 2026-05-12 | S-8 | S-8 | 0001193125-26-219912 | 333-295816 | 26970040 | 33 | 190636 | 1 | 1 | |
| 2026-05-12 | 10-Q | 10-Q | 0001660334-26-000014 | 001-38529 | 26968721 | 34 | 5041866 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-219395 | 001-38529 | 26968498 | 34 | 249215 | 1 | 1 |
| 2026-04-20 | ARS | ARS | 0001193125-26-164036 | 001-38529 | 26875261 | 34 | 1425950 | |||
| 2026-04-20 | DEFA14A | DEFA14A | 0001193125-26-164025 | 001-38529 | 26875228 | 34 | 796389 | |||
| 2026-04-20 | DEF 14A | DEF 14A | 0001193125-26-163961 | 001-38529 | 26875134 | 34 | 2665319 | 1 | 1 | |
| 2026-03-11 | 10-K | 10-K | 0001660334-26-000008 | 001-38529 | 26741603 | 34 | 10575306 | 1 | 1 | |
| 2026-03-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-101126 | 001-38529 | 26741595 | 34 | 309983 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001229 | 005-90530 | 26645057 | 34 | 10647 | |||
| 2026-02-02 | 3/A | xslF345X02/form3a-02022026_020243.xml | 0002101167-26-000004 | 5345 | ||||||
| 2026-01-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001315863-26-000100 | 005-90530 | 26579990 | 34 | 14730 | |||
| 2026-01-26 | 3 | xslF345X02/form3-01262026_090154.xml | 0002101167-26-000002 | 7250 | ||||||
| 2025-12-30 | 4 | xslF345X05/form4-12302025_081201.xml | 0001556327-25-000006 | 4746 | ||||||
| 2025-12-30 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-25-005417 | 005-90530 | 251611052 | 34 | 9363 | |||
| 2025-12-30 | 3 | xslF345X02/ownership.xml | 0000902664-25-005416 | 10941 | ||||||
| 2025-12-30 | 3 | xslF345X02/ownership.xml | 0000902664-25-005415 | 2990 | ||||||
| 2025-12-30 | 8-K | 8-K | 5.02 | 0001193125-25-335824 | 001-38529 | 251611005 | 34 | 142649 | 1 | 1 |
| 2025-12-23 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003919 | 333-292140 | 251602300 | 33 | 1774 | ||
| 2025-12-23 | 424B3 | 424B3 | 0001193125-25-330986 | 333-292140 | 251600903 | 33 | 164342 | |||
| 2025-12-19 | CORRESP | filename1.htm | 0001193125-25-326765 | 7022 | ||||||
| 2025-12-15 | S-3 | S-3 | 0001193125-25-319225 | 333-292140 | 251571787 | 33 | 369119 | 1 | 1 | |
| 2025-12-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-25-000594 | 021-566413 | 251561991 | 33 | 15097 | ||
| 2025-12-03 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001011438-25-000591 | 005-90530 | 251546220 | 34 | 15120 | |||
| 2025-11-28 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001494695-25-000006 | 005-90530 | 251536453 | 34 | 12092 | |||
| 2025-11-25 | 4 | xslF345X05/form4-11252025_071113.xml | 0001579649-25-000004 | 7464 | ||||||
| 2025-11-25 | 4 | xslF345X05/form4-11252025_071111.xml | 0001556327-25-000004 | 7727 | ||||||
| 2025-11-25 | 4 | xslF345X05/form4-11252025_071109.xml | 0002046750-25-000004 | 7768 | ||||||
| 2025-11-25 | 4 | xslF345X05/form4-11252025_071107.xml | 0002043558-25-000003 | 11213 | ||||||
| 2025-11-25 | 4 | xslF345X05/form4-11252025_071105.xml | 0001494695-25-000004 | 17359 | ||||||
| 2025-11-24 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-25-005145 | 005-90530 | 251513183 | 34 | 25325 | |||
| 2025-11-24 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-25-292155 | 001-38529 | 251509647 | 34 | 1105426 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-005162 | 005-90530 | 251488697 | 34 | 10669 | |||
| 2025-11-14 | 10-Q | 10-Q | 0001660334-25-000006 | 001-38529 | 251487309 | 34 | 6517622 | 1 | 1 | |
| 2025-11-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-283078 | 001-38529 | 251486892 | 34 | 295826 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003622 | 005-90530 | 251222234 | 34 | 10579 | |||
| 2025-08-12 | 10-Q | 10-Q | 0000950170-25-107358 | 001-38529 | 251207037 | 34 | 10713578 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-178954 | 001-38529 | 251206802 | 34 | 291339 | 1 | 1 |
| 2025-07-30 | 8-K | 8-K | 3.01 | 0001193125-25-169309 | 001-38529 | 251167237 | 34 | 142566 | 1 | 1 |
| 2025-07-23 | 8-K | 8-K | 3.03,9.01 | 0001193125-25-162939 | 001-38529 | 251141640 | 34 | 155014 | 1 | 1 |
| 2025-07-01 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-25-153471 | 001-38529 | 251094199 | 34 | 175142 | 1 | 1 |
| 2025-06-12 | 8-K | 8-K | 1.01 | 0001193125-25-139959 | 001-38529 | 251043137 | 34 | 137498 | 1 | 1 |
| 2025-06-09 | 4 | xslF345X05/form4-06092025_040607.xml | 0001415889-25-016290 | 5611 | ||||||
| 2025-06-09 | 4 | xslF345X05/form4-06092025_040603.xml | 0001415889-25-016288 | 5619 | ||||||
| 2025-06-09 | 4 | xslF345X05/form4-06092025_040601.xml | 0001415889-25-016287 | 5631 | ||||||
| 2025-06-09 | 4 | xslF345X05/form4-06092025_040605.xml | 0001415889-25-016289 | 5595 | ||||||
| 2025-06-05 | 8-K | 8-K | 5.07 | 0001193125-25-135949 | 001-38529 | 251027888 | 34 | 150616 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-072737 | 005-90530 | 25954082 | 34 | 10801 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002236 | 005-90530 | 25951887 | 34 | 10578 | |||
| 2025-05-13 | S-8 | S-8 | 0001193125-25-118881 | 333-287233 | 25940982 | 33 | 70913 | |||
| 2025-05-13 | 10-Q | 10-Q | 0000950170-25-070452 | 001-38529 | 25940799 | 34 | 8857448 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-118839 | 001-38529 | 25940421 | 34 | 241347 | 1 | 1 |
| 2025-04-30 | DEFR14A | DEFR14A | 0001193125-25-105562 | 001-38529 | 25890662 | 34 | 3185241 | 1 | 1 | |
| 2025-04-25 | 8-K | 8-K | 5.02,9.01 | 0001193125-25-096909 | 001-38529 | 25874440 | 34 | 183251 | 1 | 1 |
| 2025-04-22 | ARS | ARS | 0001193125-25-087842 | 001-38529 | 25854964 | 34 | 802451 | |||
| 2025-04-22 | DEFA14A | DEFA14A | 0001193125-25-087840 | 001-38529 | 25854962 | 34 | 966532 | |||
| 2025-04-22 | DEF 14A | DEF 14A | 0001193125-25-087838 | 001-38529 | 25854957 | 34 | 3055110 | 1 | 1 | |
| 2025-04-11 | PRE 14A | PRE 14A | 0001193125-25-079118 | 001-38529 | 25832269 | 34 | 3069723 | 1 | 1 | |
| 2025-04-02 | 4 | xslF345X05/form4-04022025_080448.xml | 0001415889-25-009654 | 5565 | ||||||
| 2025-04-02 | 3 | xslF345X02/form3-04022025_080447.xml | 0001415889-25-009651 | 10821 | ||||||
| 2025-04-02 | 8-K | 8-K | 5.02 | 0001193125-25-071389 | 001-38529 | 25805237 | 34 | 147949 | 1 | 1 |
| 2025-03-26 | 4 | xslF345X05/form4-03262025_110341.xml | 0001415889-25-008999 | 5608 | ||||||
| 2025-03-26 | 3 | xslF345X02/form3-03262025_110359.xml | 0001415889-25-008997 | 9641 | ||||||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000779 | 333-285719 | 25769889 | 33 | 1773 | ||
| 2025-03-21 | CORRESP | filename1.htm | 0001193125-25-059980 | 8045 | ||||||
| 2025-03-18 | 4 | xslF345X05/form4-03182025_060303.xml | 0001415889-25-008506 | 5620 | ||||||
| 2025-03-18 | 4 | xslF345X05/form4-03182025_060301.xml | 0001415889-25-008505 | 8074 | ||||||
| 2025-03-17 | UPLOAD | filename1.pdf | 0000000000-25-002888 | 333-285719 | 40106 | |||||
| 2025-03-11 | S-3 | S-3 | 0001193125-25-052031 | 333-285719 | 25728560 | 33 | 1839118 | |||
| 2025-03-11 | 10-K | 10-K | 0000950170-25-037172 | 001-38529 | 25727942 | 34 | 12350499 | 1 | 1 | |
| 2025-03-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-051957 | 001-38529 | 25727781 | 34 | 297838 | 1 | 1 |
| 2025-02-21 | 8-K | 8-K | 1.01 | 0001193125-25-032003 | 001-38529 | 25652095 | 34 | 144507 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001240 | 005-90530 | 25630577 | 34 | 10440 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-021211 | 005-90530 | 25628900 | 34 | 11641 | |||
| 2025-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000897 | 005-90530 | 25614792 | 34 | 16886 | |||
| 2025-02-06 | 4/A | xslF345X05/form4a-02062025_040211.xml | 0001415889-25-003234 | 5580 | ||||||
| 2025-02-06 | 4/A | xslF345X05/form4a-02062025_040208.xml | 0001415889-25-003233 | 5570 | ||||||
| 2025-02-06 | 4/A | xslF345X05/form4a-02062025_040206.xml | 0001415889-25-003232 | 5589 | ||||||
| 2025-02-06 | 4/A | xslF345X05/form4a-02062025_040204.xml | 0001415889-25-003231 | 5564 | ||||||
| 2025-02-06 | 4/A | xslF345X05/form4a-02062025_040201.xml | 0001415889-25-003230 | 5582 | ||||||
| 2025-01-30 | 8-K | 8-K | 3.01 | 0001193125-25-017264 | 001-38529 | 25573955 | 34 | 146986 | 1 | 1 |
| 2024-12-09 | SC 13G/A | SC 13G/A | 0001193125-24-273581 | 005-90530 | 241536570 | 34 | 60272 | |||
| 2024-12-09 | 4 | xslF345X05/form4-12092024_101222.xml | 0001415889-24-028674 | 5627 | ||||||
| 2024-12-09 | 3 | xslF345X02/form3-12092024_101242.xml | 0001415889-24-028671 | 10506 | ||||||
| 2024-12-09 | S-8 | S-8 | 0001193125-24-273484 | 333-283694 | 241535779 | 33 | 73076 | |||
| 2024-12-09 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-273406 | 001-38529 | 241535192 | 34 | 203691 | 1 | 1 |
| 2024-11-26 | SC 13D/A | SC 13D/A | 0001104659-24-123093 | 005-90530 | 241503979 | 34 | 65596 | |||
| 2024-11-26 | 4 | xslF345X05/form4-11262024_041106.xml | 0001415889-24-027711 | 14420 | ||||||
| 2024-11-26 | 4 | xslF345X05/form4-11262024_041104.xml | 0001415889-24-027710 | 11201 | ||||||
| 2024-11-26 | 4 | xslF345X05/form4-11262024_041101.xml | 0001415889-24-027709 | 22437 | ||||||
| 2024-11-21 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-263477 | 001-38529 | 241485229 | 34 | 739263 | 1 | 1 |
| 2024-11-21 | 424B5 | 424B5 | 0001193125-24-263473 | 333-268229 | 241485181 | 33 | 651029 | |||
| 2024-11-20 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-262615 | 001-38529 | 241481278 | 34 | 191105 | 1 | 1 |
| 2024-11-20 | 424B5 | 424B5 | 0001193125-24-262611 | 333-268229 | 241481249 | 33 | 653130 | |||
| 2024-11-14 | SC 13G/A | VERRICA PHARMACEUTICALS INC. | 0000902664-24-006523 | 005-90530 | 241457811 | 34 | 58612 | |||
| 2024-11-06 | 4 | xslF345X05/form4-11072024_021129.xml | 0001415889-24-026290 | 4901 | ||||||
| 2024-11-06 | 3 | xslF345X02/form3-11072024_021141.xml | 0001415889-24-026288 | 9491 | ||||||
| 2024-11-06 | 4 | xslF345X05/form4-11072024_021140.xml | 0001415889-24-026286 | 5621 | ||||||
| 2024-11-06 | 3 | xslF345X02/form3-11072024_011112.xml | 0001415889-24-026284 | 13491 | ||||||
| 2024-11-06 | S-8 | S-8 | 0001193125-24-252195 | 333-283039 | 241432172 | 33 | 97668 | |||
| 2024-11-05 | 10-Q | 10-Q | 0000950170-24-120982 | 001-38529 | 241425035 | 34 | 7273717 | 1 | 1 | |
| 2024-11-04 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-24-250638 | 001-38529 | 241423814 | 34 | 782236 | 1 | 1 |
| 2024-10-11 | 4 | xslF345X05/form4-10112024_041004.xml | 0001415889-24-025026 | 5552 | ||||||
| 2024-10-08 | 8-K | 8-K | 3.01,5.02 | 0001193125-24-234391 | 001-38529 | 241360496 | 34 | 146382 | 1 | 1 |
| 2024-10-01 | 8-K | 8-K | 2.05 | 0001193125-24-230240 | 001-38529 | 241343888 | 34 | 144473 | 1 | 1 |
| 2024-09-27 | 8-K | 8-K | 5.02 | 0001193125-24-227975 | 001-38529 | 241335071 | 34 | 142678 | 1 | 1 |
| 2024-09-23 | 4 | xslF345X05/form4-09232024_040901.xml | 0001415889-24-023835 | 13778 | ||||||
| 2024-09-06 | 8-K | 8-K | 5.02 | 0001193125-24-215180 | 001-38529 | 241284724 | 34 | 144830 | 1 | 1 |
| 2024-08-28 | 4 | xslF345X05/form4-08282024_040809.xml | 0001415889-24-022427 | 7460 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_040807.xml | 0001415889-24-022426 | 7449 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_040805.xml | 0001415889-24-022425 | 7451 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_040804.xml | 0001415889-24-022424 | 7439 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_040801.xml | 0001415889-24-022423 | 7435 | ||||||
| 2024-08-27 | 8-K | 8-K | 5.02 | 0001193125-24-207814 | 001-38529 | 241249808 | 34 | 145306 | 1 | 1 |
| 2024-08-26 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000312 | 001-38529 | 241242016 | 33 | 5574 | |||
| 2024-08-26 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000311 | 001-38529 | 241241912 | 33 | 5554 | |||
| 2024-08-26 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000310 | 001-38529 | 241240815 | 33 | 5537 | |||
| 2024-08-26 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000309 | 001-38529 | 241240639 | 33 | 5586 | |||
| 2024-08-26 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000308 | 001-38529 | 241240584 | 33 | 4389 | |||
| 2024-08-14 | 10-Q | 10-Q | 0000950170-24-096669 | 001-38529 | 241204275 | 34 | 7260507 | 1 | 1 | |
| 2024-08-14 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-24-200247 | 001-38529 | 241204220 | 34 | 7397631 | 1 | 1 |
| 2024-08-05 | 8-K | 8-K | 1.01 | 0001193125-24-193923 | 001-38529 | 241174979 | 34 | 144216 | 1 | 1 |
| 2024-07-23 | 4 | xslF345X05/form4-07232024_100700.xml | 0001415889-24-019976 | 7209 | ||||||
| 2024-07-23 | 4 | xslF345X05/form4-07232024_100716.xml | 0001415889-24-019974 | 7227 | ||||||
| 2024-07-23 | 4 | xslF345X05/form4-07232024_100729.xml | 0001415889-24-019972 | 7225 | ||||||
| 2024-07-23 | 4 | xslF345X05/form4-07232024_100729.xml | 0001415889-24-019970 | 7233 | ||||||
| 2024-07-22 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000250 | 001-38529 | 241131479 | 33 | 4380 | |||
| 2024-07-22 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000249 | 001-38529 | 241131458 | 33 | 4391 | |||
| 2024-07-22 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000248 | 001-38529 | 241131445 | 33 | 4410 | |||
| 2024-07-22 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000247 | 001-38529 | 241131432 | 33 | 4402 | |||
| 2024-06-28 | 8-K | 8-K | 1.01 | 0001193125-24-172277 | 001-38529 | 241085984 | 34 | 145237 | 1 | 1 |
| 2024-06-10 | 8-K | 8-K | 5.07 | 0001193125-24-158353 | 001-38529 | 241032976 | 34 | 158121 | 1 | 1 |
| 2024-06-07 | 4 | xslF345X05/form4-06072024_040613.xml | 0001415889-24-015961 | 5601 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06072024_040609.xml | 0001415889-24-015959 | 5637 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06072024_040611.xml | 0001415889-24-015960 | 5625 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06072024_040607.xml | 0001415889-24-015958 | 5631 | ||||||
| 2024-05-15 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-24-138898 | 001-38529 | 24947192 | 34 | 192148 | 1 | 1 |
| 2024-05-13 | S-8 | S-8 | 0001193125-24-137265 | 333-279373 | 24939615 | 33 | 72737 | |||
| 2024-05-13 | 10-Q | 10-Q | 0000950170-24-058208 | 001-38529 | 24936948 | 34 | 6008612 | 1 | 1 | |
| 2024-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-136715 | 001-38529 | 24936909 | 34 | 245474 | 1 | 1 |
| 2024-04-19 | ARS | ARS | 0001193125-24-101659 | 001-38529 | 24855630 | 34 | 775738 | |||
| 2024-04-19 | DEFA14A | DEFA14A | 0001193125-24-101652 | 001-38529 | 24855624 | 34 | 993322 | |||
| 2024-04-19 | DEF 14A | DEF 14A | 0001193125-24-101650 | 001-38529 | 24855616 | 34 | 1188762 | |||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_040300.xml | 0001415889-24-008543 | 7475 | ||||||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_040351.xml | 0001415889-24-008542 | 7467 | ||||||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_040349.xml | 0001415889-24-008541 | 7455 | ||||||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_040347.xml | 0001415889-24-008539 | 7468 | ||||||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_040342.xml | 0001415889-24-008538 | 7454 | ||||||
| 2024-02-29 | 10-K | 10-K | 0000950170-24-022659 | 001-38529 | 24698975 | 34 | 9454903 | 1 | 1 | |
| 2024-02-29 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-051876 | 001-38529 | 24698910 | 34 | 260662 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036433 | 005-90530 | 24639678 | 34 | 64500 | |||
| 2024-02-14 | SC 13G | VERRICA PHARMACEUTICALS INC. | 0000902664-24-001598 | 005-90530 | 24632931 | 34 | 65105 | |||
| 2024-01-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-003926 | 001-38529 | 24518403 | 34 | 18257380 | 1 | 1 |
| 2023-12-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-023292 | 13160 | ||||||
| 2023-12-26 | 4 | FORM 4 SUBMISSION | 0000899243-23-020691 | 13639 | ||||||
| 2023-12-19 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-022861 | 13164 | ||||||
| 2023-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-055542 | 7181 | ||||||
| 2023-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-055534 | 7177 | ||||||
| 2023-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-055531 | 7167 | ||||||
| 2023-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-055528 | 7165 | ||||||
| 2023-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-055527 | 7189 | ||||||
| 2023-11-16 | 144/A | xsl144X01/primary_doc.xml | 0001974078-23-000206 | 001-38529 | 231412855 | 33 | 4393 | |||
| 2023-11-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000204 | 001-38529 | 231411272 | 33 | 4370 | |||
| 2023-11-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000203 | 001-38529 | 231411147 | 33 | 4399 | |||
| 2023-11-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000200 | 001-38529 | 231410870 | 33 | 4380 | |||
| 2023-11-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000199 | 001-38529 | 231410784 | 33 | 4354 | |||
| 2023-11-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000198 | 001-38529 | 231410622 | 33 | 4378 | |||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-061543 | 001-38529 | 231390117 | 34 | 10582477 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-274069 | 001-38529 | 231390098 | 34 | 292643 | 1 | 1 |
| 2023-08-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-047524 | 4895 | ||||||
| 2023-08-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-047523 | 4891 | ||||||
| 2023-08-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-047521 | 4915 | ||||||
| 2023-08-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-047519 | 4906 | ||||||
| 2023-08-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-047518 | 4908 | ||||||
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039375 | 001-38529 | 231149388 | 34 | 6830592 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-205590 | 001-38529 | 231149371 | 34 | 262535 | 1 | 1 |
| 2023-07-27 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-196112 | 001-38529 | 231118593 | 34 | 6667774 | 1 | 1 |
| 2023-07-27 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000097 | 001-38529 | 231116866 | 33 | 4297 | |||
| 2023-07-27 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000096 | 001-38529 | 231116845 | 33 | 4341 | |||
| 2023-07-27 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000095 | 001-38529 | 231116816 | 33 | 4313 | |||
| 2023-07-27 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000094 | 001-38529 | 231116773 | 33 | 4294 | |||
| 2023-07-26 | 8-K | 8-K | 1.01,2.03,3.02,7.01,9.01 | 0001193125-23-194625 | 001-38529 | 231113890 | 34 | 191710 | 1 | 1 |
| 2023-07-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-043306 | 7392 | ||||||
| 2023-07-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-043304 | 7374 | ||||||
| 2023-07-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-043301 | 7385 | ||||||
| 2023-07-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-043297 | 7369 | ||||||
| 2023-07-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-043255 | 8136 | ||||||
| 2023-07-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-191859 | 001-38529 | 231103756 | 34 | 3063850 | 1 | 1 |
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036151 | 5557 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036149 | 5563 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036147 | 5551 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036145 | 5527 | ||||||
| 2023-06-08 | 8-K | 8-K | 5.07 | 0001193125-23-163516 | 001-38529 | 231002114 | 34 | 154413 | 1 | 1 |
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019169 | 001-38529 | 23900110 | 34 | 6163006 | 1 | 1 | |
| 2023-05-09 | S-8 | S-8 | 0001193125-23-138960 | 333-271747 | 23900103 | 33 | 70771 | |||
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-138946 | 001-38529 | 23900085 | 34 | 228447 | 1 | 1 |
| 2023-04-21 | DEFA14A | DEFA14A | 0001193125-23-109458 | 001-38529 | 23834739 | 34 | 652855 | |||
| 2023-04-21 | DEF 14A | DEF 14A | 0001193125-23-109424 | 001-38529 | 23834699 | 34 | 955502 | |||
| 2023-04-21 | ARS | ARS | 0001193125-23-109412 | 001-38529 | 23834684 | 34 | 1122028 | |||
| 2023-03-06 | 10-K | 10-K | 0000950170-23-006118 | 001-38529 | 23707608 | 34 | 10439829 | 1 | 1 | |
| 2023-03-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-060702 | 001-38529 | 23707583 | 34 | 247778 | 1 | 1 |
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015511 | 5574 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015507 | 5588 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015503 | 5576 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015497 | 5587 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015492 | 5598 | ||||||
| 2023-02-22 | 424B5 | 424B5 | 0001193125-23-044839 | 333-268229 | 23653364 | 33 | 597413 | |||
| 2023-02-21 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-011127 | 4903 | ||||||
| 2023-02-21 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-23-043040 | 001-38529 | 23645461 | 34 | 540434 | 1 | 1 |
| 2023-02-21 | FWP | FWP | 0001193125-23-042777 | 333-268229 | 23645157 | 34 | 28899 | |||
| 2023-02-21 | 8-K | 8-K | 2.02,8.01 | 0001193125-23-042756 | 001-38529 | 23645119 | 34 | 155705 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-038756 | 005-90530 | 23627315 | 34 | 64811 | |||
| 2023-02-02 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-022755 | 001-38529 | 23581127 | 34 | 20548031 | 1 | 1 |
| 2023-01-24 | 8-K | 8-K | 8.01 | 0001193125-23-013704 | 001-38529 | 23545881 | 34 | 146617 | 1 | 1 |
| 2022-12-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-12-19 09:00:00 | 9999999995-22-003580 | 333-268229 | 221472770 | 33 | 1732 | ||
| 2022-12-19 | 424B5 | 424B5 | 0001193125-22-308333 | 333-268229 | 221471267 | 33 | 191733 | |||
| 2022-12-15 | CORRESP | filename1.htm | 0001193125-22-305993 | 77292 | ||||||
| 2022-11-29 | UPLOAD | filename1.pdf | 0000000000-22-012873 | 39640 | ||||||
| 2022-11-18 | CORRESP | filename1.htm | 0001193125-22-288375 | 28422 | ||||||
| 2022-11-15 | UPLOAD | filename1.pdf | 0000000000-22-012371 | 40209 | ||||||
| 2022-11-08 | UPLOAD | filename1.pdf | 0000000000-22-012149 | 44709 | ||||||
| 2022-11-07 | S-3 | S-3 | 0001193125-22-279251 | 333-268229 | 221366528 | 33 | 1359859 | |||
| 2022-11-07 | 10-Q | 10-Q | 0000950170-22-022647 | 001-38529 | 221365880 | 34 | 8006483 | 1 | 1 | |
| 2022-11-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-279108 | 001-38529 | 221365733 | 34 | 264397 | 1 | 1 |
| 2022-09-14 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-244283 | 001-38529 | 221242106 | 34 | 24811248 | 1 | 1 |
| 2022-08-11 | 10-Q | 10-Q | 0000950170-22-016660 | 001-38529 | 221153770 | 34 | 7984470 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-218004 | 001-38529 | 221153732 | 34 | 257137 | 1 | 1 |
| 2022-07-15 | SC 13D | SC 13D | 0001104659-22-080215 | 005-90530 | 221086464 | 34 | 82917 | |||
| 2022-07-13 | 8-K | 8-K | 8.01 | 0001193125-22-192901 | 001-38529 | 221081242 | 34 | 148222 | 1 | 1 |
| 2022-07-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-041835 | 4611 | ||||||
| 2022-07-05 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-015932 | 8555 | ||||||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-040616 | 4610 | ||||||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-040608 | 4588 | ||||||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-040600 | 4604 | ||||||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-040591 | 4625 | ||||||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-040581 | 6570 | ||||||
| 2022-07-01 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-186748 | 001-38529 | 221059694 | 34 | 415864 | 1 | 1 |
| 2022-07-01 | 424B5 | 424B5 | 0001193125-22-186744 | 333-237171 | 221059687 | 33 | 520464 | |||
| 2022-06-29 | 424B5 | 424B5 | 0001193125-22-185052 | 333-237171 | 221054759 | 33 | 523994 | |||
| 2022-06-14 | 8-K | 8-K | 5.07 | 0001193125-22-173863 | 001-38529 | 221015252 | 34 | 154808 | 1 | 1 |
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036300 | 5525 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036298 | 5495 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036297 | 5531 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036293 | 5519 | ||||||
| 2022-06-03 | 8-K | 8-K | 2.05 | 0001193125-22-167332 | 001-38529 | 22994605 | 34 | 147641 | 1 | 1 |
| 2022-05-25 | 8-K | 8-K | 8.01 | 0001193125-22-159075 | 001-38529 | 22958881 | 34 | 147501 | 1 | 1 |
| 2022-05-09 | S-8 | S-8 | 0001193125-22-144468 | 333-264784 | 22903513 | 33 | 70776 | |||
| 2022-05-09 | 10-Q | 10-Q | 0000950170-22-008242 | 001-38529 | 22903278 | 34 | 7187793 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-144294 | 001-38529 | 22903262 | 34 | 228725 | 1 | 1 |
| 2022-04-22 | DEFA14A | DEFA14A | 0001193125-22-115138 | 001-38529 | 22845603 | 34 | 539791 | |||
| 2022-04-22 | DEF 14A | DEF 14A | 0001193125-22-115092 | 001-38529 | 22845498 | 34 | 475324 | |||
| 2022-04-07 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-098900 | 001-38529 | 22814078 | 34 | 24324032 | 1 | 1 |
| 2022-03-02 | 10-K | 10-K | 0000950170-22-002685 | 001-38529 | 22704630 | 34 | 11934285 | 1 | 1 | |
| 2022-03-02 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-063013 | 001-38529 | 22703878 | 34 | 241947 | 1 | 1 |
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013202 | 5599 | ||||||
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013199 | 5591 | ||||||
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013196 | 5580 | ||||||
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013193 | 5592 | ||||||
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013191 | 5578 | ||||||
| 2022-02-14 | 5 | FORM 5 SUBMISSION | 0001209191-22-009596 | 6773 | ||||||
| 2022-02-14 | SC 13G/A | AMENDMENT TO FORM SC 13G | 0001387131-22-001917 | 005-90530 | 22633275 | 34 | 79345 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-041545 | 005-90530 | 22630923 | 34 | 67702 | |||
| 2022-02-11 | SC 13G/A | AMENDMENT NO. 1 | 0000947871-22-000217 | 005-90530 | 22622286 | 34 | 66127 | |||
| 2022-01-27 | SC 13G/A | SC 13G/A | 0001193125-22-019277 | 005-90530 | 22561406 | 34 | 45569 | |||
| 2021-12-15 | 8-K | FORM 8-K | 8.01 | 0001193125-21-357955 | 001-38529 | 211494476 | 34 | 147496 | 1 | 1 |
| 2021-12-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-068031 | 10195 | ||||||
| 2021-11-29 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-342387 | 001-38529 | 211457181 | 34 | 24789303 | 1 | 1 |
| 2021-11-12 | 10-Q | 10-Q | 0000950170-21-004249 | 001-38529 | 211399664 | 34 | 8431341 | 1 | 1 | |
| 2021-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-327358 | 001-38529 | 211399623 | 34 | 253271 | 1 | 1 |
| 2021-09-29 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-286746 | 001-38529 | 211291697 | 34 | 24782361 | 1 | 1 |
| 2021-09-20 | 8-K | 8-K | 8.01 | 0001193125-21-277323 | 001-38529 | 211263552 | 34 | 148069 | 1 | 1 |
| 2021-08-10 | 10-Q | 10-Q | 0001564590-21-042894 | 001-38529 | 211158479 | 34 | 7465536 | 1 | 1 | |
| 2021-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-241222 | 001-38529 | 211158469 | 34 | 257508 | 1 | 1 |
| 2021-07-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-047477 | 5581 | ||||||
| 2021-07-20 | 3 | FORM 3 SUBMISSION | 0001209191-21-047472 | 7101 | ||||||
| 2021-07-09 | 8-K | 8-K | 5.02 | 0001193125-21-211337 | 001-38529 | 211081708 | 34 | 161448 | 1 | 1 |
| 2021-06-17 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-041449 | 5953 | ||||||
| 2021-06-17 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-041447 | 5977 | ||||||
| 2021-06-17 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-041444 | 5983 | ||||||
| 2021-06-17 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-041443 | 5989 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040269 | 5524 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040267 | 5494 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040265 | 5530 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040264 | 5518 | ||||||
| 2021-06-10 | 8-K | 8-K | 5.07 | 0001193125-21-187840 | 001-38529 | 211008587 | 34 | 155204 | 1 | 1 |
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038482 | 5122 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038481 | 5146 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038480 | 5135 | ||||||
| 2021-05-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-176231 | 001-38529 | 21976126 | 34 | 170413 | 1 | 1 |
| 2021-05-07 | S-8 | S-8 | 0001193125-21-155019 | 333-255919 | 21903426 | 33 | 67312 | |||
| 2021-05-07 | 10-Q | 10-Q | 0001564590-21-025318 | 001-38529 | 21900330 | 34 | 7460714 | 1 | 1 | |
| 2021-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-154092 | 001-38529 | 21900273 | 34 | 228866 | 1 | 1 |
| 2021-04-23 | DEFA14A | DEFA14A | 0001193125-21-127788 | 001-38529 | 21846667 | 34 | 156417 | |||
| 2021-04-23 | DEF 14A | DEF 14A | 0001193125-21-127783 | 001-38529 | 21846661 | 34 | 492384 | |||
| 2021-04-19 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-001357 | 274569 | ||||||
| 2021-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-023388 | 7665 | ||||||
| 2021-03-23 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-21-091371 | 001-38529 | 21765666 | 34 | 432050 | 1 | 1 |
| 2021-03-23 | 424B5 | 424B5 | 0001193125-21-091358 | 333-237171 | 21765650 | 33 | 520420 | |||
| 2021-03-22 | 424B5 | 424B5 | 0001193125-21-089577 | 333-237171 | 21761602 | 33 | 524666 | |||
| 2021-03-22 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000552 | 277077 | ||||||
| 2021-03-17 | 10-K | 10-K | 0001564590-21-013876 | 001-38529 | 21750838 | 34 | 10301398 | 1 | 1 | |
| 2021-03-17 | 8-K | 8-K | 1.01 | 0001193125-21-083540 | 001-38529 | 21748485 | 34 | 152996 | 1 | 1 |
| 2021-03-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-21-068558 | 001-38529 | 21712657 | 34 | 215726 | 1 | 1 |
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017004 | 5577 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016997 | 5588 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016984 | 5590 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016978 | 5591 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016972 | 5598 | ||||||
| 2021-02-17 | 8-K | FORM 8-K | 8.01,9.01 | 0001193125-21-045850 | 001-38529 | 21642723 | 34 | 173415 | 1 | 1 |
| 2021-02-17 | SC 13G/A | SC 13G/A | 0001193125-21-045466 | 005-90530 | 21642226 | 34 | 64532 | |||
| 2021-02-16 | SC 13G/A | AMENDMENT TO FORM SC13G | 0001387131-21-002489 | 005-90530 | 21638008 | 34 | 141123 | |||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001193125-21-044763 | 005-90530 | 21637471 | 34 | 65256 | |||
| 2021-01-25 | SC 13G/A | SC 13G/A | 0001193125-21-016443 | 005-90530 | 21550726 | 34 | 48536 | |||
| 2021-01-06 | 8-K | FORM 8-K | 7.01,9.01 | 0001193125-21-002410 | 001-38529 | 21508927 | 34 | 11715397 | 1 | 1 |
| 2020-12-23 | 8-K | FORM 8-K | 8.01 | 0001193125-20-325991 | 001-38529 | 201412366 | 34 | 147243 | 1 | 1 |
| 2020-11-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-20-289663 | 001-38529 | 201299663 | 34 | 23890549 | 1 | 1 |
| 2020-11-09 | 10-Q | 10-Q | 0001564590-20-052242 | 001-38529 | 201296291 | 34 | 7826003 | 1 | 1 | |
| 2020-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-288501 | 001-38529 | 201296123 | 34 | 207150 | 1 | 1 |
| 2020-09-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-20-240495 | 001-38529 | 201162929 | 34 | 15126178 | 1 | 1 |
| 2020-08-26 | 4 | FORM 4 SUBMISSION | 0001209191-20-048401 | 6847 | ||||||
| 2020-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-047865 | 7182 | ||||||
| 2020-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-047409 | 7181 | ||||||
| 2020-08-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-047100 | 7179 | ||||||
| 2020-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-046963 | 6828 | ||||||
| 2020-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-046962 | 5137 | ||||||
| 2020-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-046961 | 5120 | ||||||
| 2020-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-046880 | 9400 | ||||||
| 2020-08-11 | 8-K | FORM 8-K | 1.01 | 0001193125-20-215626 | 001-38529 | 201091058 | 34 | 153321 | 1 | 1 |
| 2020-08-05 | 10-Q | 10-Q | 0001564590-20-036455 | 001-38529 | 201075712 | 34 | 6670358 | 1 | 1 | |
| 2020-08-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-20-209871 | 001-38529 | 201075636 | 34 | 68191 | ||
| 2020-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-044549 | 5592 | ||||||
| 2020-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-044548 | 5523 | ||||||
| 2020-08-03 | 3 | FORM 3 SUBMISSION | 0001209191-20-044547 | 8417 | ||||||
| 2020-07-23 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001193125-20-197468 | 001-38529 | 201042752 | 34 | 66849 | ||
| 2020-07-14 | 8-K | FORM 8-K | 2.02,8.01,9.01 | 0001193125-20-192263 | 001-38529 | 201026302 | 34 | 43046 | ||
| 2020-06-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-182369 | 001-38529 | 20997625 | 34 | 41603 | ||
| 2020-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-20-036345 | 5527 | ||||||
| 2020-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-20-036321 | 5525 | ||||||
| 2020-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-20-036318 | 5495 | ||||||
| 2020-06-11 | 4 | FORM 4 SUBMISSION | 0001209191-20-035997 | 5509 | ||||||
| 2020-06-11 | 3 | FORM 3 SUBMISSION | 0001209191-20-035994 | 7621 | ||||||
| 2020-06-11 | 8-K | 8-K | 5.07 | 0001193125-20-166653 | 001-38529 | 20957349 | 34 | 24119 | ||
| 2020-06-10 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001193125-20-165142 | 001-38529 | 20953501 | 34 | 39910 | ||
| 2020-05-07 | 10-Q | 10-Q | 0001564590-20-022364 | 001-38529 | 20854568 | 34 | 6121655 | 1 | ||
| 2020-05-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-20-135570 | 001-38529 | 20854543 | 34 | 58785 | ||
| 2020-04-24 | DEFA14A | DEFA14A | 0001193125-20-118149 | 001-38529 | 20812487 | 34 | 87487 | |||
| 2020-04-24 | DEF 14A | DEF 14A | 0001193125-20-118119 | 001-38529 | 20812481 | 34 | 468908 | |||
| 2020-04-17 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-20-109995 | 001-38529 | 20797769 | 34 | 21360077 | ||
| 2020-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-03-25 16:30:00 | 9999999995-20-000620 | 333-237171 | 20743866 | 33 | 1731 | ||
| 2020-03-23 | CORRESP | filename1.htm | 0001193125-20-082429 | 5853 | ||||||
| 2020-03-23 | UPLOAD | filename1.pdf | 0000000000-20-002517 | 39901 | ||||||
| 2020-03-13 | S-8 | FORM S-8 | 0001193125-20-073011 | 333-237174 | 20713522 | 33 | 66395 | |||
| 2020-03-13 | S-3 | FORM S-3 | 0001193125-20-072993 | 333-237171 | 20713459 | 33 | 1010745 | |||
| 2020-03-13 | 10-K | 10-K | 0001564590-20-010832 | 001-38529 | 20712934 | 34 | 10294242 | 1 | ||
| 2020-03-13 | 8-K | FORM 8-K | 1.01,2.02,2.03,7.01,9.01 | 0001193125-20-072873 | 001-38529 | 20712652 | 34 | 104685 | ||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015606 | 5598 | ||||||
| 2020-03-03 | 3 | FORM 3 SUBMISSION | 0001209191-20-015596 | 9790 | ||||||
| 2020-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-014686 | 5581 | ||||||
| 2020-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-014683 | 5592 | ||||||
| 2020-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-014682 | 5594 | ||||||
| 2020-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-014679 | 5595 | ||||||
| 2020-03-02 | 8-K | FORM 8-K | 7.01,9.01 | 0001193125-20-057796 | 001-38529 | 20674176 | 34 | 12360193 | ||
| 2020-02-14 | SC 13G/A | SC 13G/A | 0001193125-20-038428 | 005-90530 | 20621072 | 34 | 65814 | |||
| 2020-02-03 | SC 13G/A | SC 13G/A | 0001104659-20-009399 | 005-90530 | 20566485 | 34 | 87508 | |||
| 2020-01-30 | SC 13G/A | SC 13G/A | 0001104659-20-008705 | 005-90530 | 20561554 | 34 | 47066 | |||
| 2020-01-16 | 8-K | FORM 8-K | 5.02 | 0001193125-20-008968 | 001-38529 | 20531047 | 34 | 24184 | ||
| 2019-11-20 | 8-K | FORM 8-K | 3.01 | 0001193125-19-296660 | 001-38529 | 191234978 | 34 | 18657 | ||
| 2019-11-06 | 10-Q | 10-Q | 0001564590-19-041122 | 001-38529 | 191197134 | 34 | 6012996 | 1 | ||
| 2019-11-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-19-285916 | 001-38529 | 191196540 | 34 | 65712 | ||
| 2019-10-24 | 8-K | FORM 8-K | 5.02 | 0001193125-19-273585 | 001-38529 | 191166546 | 34 | 25435 | ||
| 2019-10-21 | 4 | FORM 4 SUBMISSION | 0001209191-19-053716 | 5586 | ||||||
| 2019-10-21 | 3 | FORM 3 SUBMISSION | 0001209191-19-053713 | 7090 | ||||||
| 2019-10-18 | 8-K | FORM 8-K | 7.01,9.01 | 0001193125-19-269686 | 001-38529 | 191156609 | 34 | 20269769 | ||
| 2019-10-10 | 4 | FORM 4 SUBMISSION | 0001209191-19-052936 | 11720 | ||||||
| 2019-10-10 | 8-K | FORM 8-K | 5.02,9.01 | 0001193125-19-265842 | 001-38529 | 191146326 | 34 | 45220 | ||
| 2019-10-04 | 8-K | 8-K | 5.02 | 0001193125-19-262750 | 001-38529 | 191138792 | 34 | 17070 | ||
| 2019-09-09 | 4 | FORM 4 SUBMISSION | 0001209191-19-048940 | 13542 | ||||||
| 2019-08-29 | 4 | FORM 4 SUBMISSION | 0001209191-19-047734 | 7319 | ||||||
| 2019-08-09 | 4 | FORM 4 SUBMISSION | 0001209191-19-045382 | 9393 | ||||||
| 2019-08-07 | 10-Q | 10-Q | 0001564590-19-030121 | 001-38529 | 191005904 | 34 | 6234852 | 1 | ||
| 2019-08-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-19-215354 | 001-38529 | 191005753 | 34 | 69235 | ||
| 2019-08-06 | 4 | FORM 4 SUBMISSION | 0001209191-19-044881 | 9394 | ||||||
| 2019-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-19-044073 | 9393 |
One latest value per concept from companyfacts (314 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 17.18M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 27.30M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 692,881 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-20 | 0001193125-26-163961 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 905,731 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-20 | 0001193125-26-163961 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 30.22 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-20 | 0001193125-26-163961 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 644.34 | 2026-05-11 | S-8 | 2026-05-12 | 0001193125-26-219912 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 644.34 | 2026-05-11 | S-8 | 2026-05-12 | 0001193125-26-219912 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 4.67M | 2026-05-11 | S-8 | 2026-05-12 | 0001193125-26-219912 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-11 | S-8 | 2026-05-12 | 0001193125-26-219912 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 11.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022659 |
| us-gaap | AccretionExpense | Accretion Expense | USD | 375,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001660334-25-000006 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 2.04M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 918,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006118 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 121.86M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001193125-18-240959 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 354.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.91M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 9,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 1.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 4.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 8.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | Assets | Assets | USD | 39.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 36.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006118 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 29,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006118 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 54.63M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006118 | |
| us-gaap | AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 7,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028111 | |
| us-gaap | AvailableForSaleEquitySecuritiesAmortizedCostBasis | Available-for-sale Equity Securities, Amortized Cost Basis | USD | 58.67M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028111 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006118 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006118 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecurities | Available-for-sale Securities, Equity Securities | USD | 58.66M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028111 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecuritiesCurrent | Available-for-sale Securities, Equity Securities, Current | USD | 79.54M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006800 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecuritiesNoncurrent | Available-for-sale Securities, Equity Securities, Noncurrent | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001564590-21-013876 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 14.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 9.58M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030121 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 10.00M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-13 | 0000950170-25-070452 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 14.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -15.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 95.6 | 2024-05-14 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 50,000 | 2024-05-14 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 17.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 17.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -67.00M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022659 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 1.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ContractWithCustomerRefundLiabilityCurrent | Contract with Customer, Refund Liability, Current | USD | 1.70M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0000950170-24-120982 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 700,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-13 | 0000950170-25-070452 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037172 |
| us-gaap | DebtCurrent | Debt, Current | USD | 40.67M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-07 | 0001564590-21-025318 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 3.80M | 2022-07-11 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022659 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.08 | 2023-07-26 | 2025 | Q2 | 10-Q | 2025-08-12 | 0000950170-25-107358 | |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 213,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -2.40M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0000950170-22-002685 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 389,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredRentCredit | Deferred Rent Credit | USD | 2,000 | 2019-01-01 | 2020 | FY | 10-K | 2021-03-17 | 0001564590-21-013876 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 481,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0000950170-25-107358 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 74.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 2.40M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001564590-21-013876 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 389,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 58.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 2.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 3.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 4.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 73.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037172 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 8,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 1.24M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | Depreciation | Depreciation | USD | 42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 600,000 | 2026-09-17 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 556,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 38,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | EarlyRepaymentOfSeniorDebt | Early Repayment of Senior Debt | USD | 35.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.65 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.31 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008242 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.65 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.159 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 410,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.023 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.019 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 1.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 300,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001564590-19-041122 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 5.50M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001660334-26-000014 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 2.40M | 2023-07-26 | 2025 | Q1 | 10-Q | 2025-05-13 | 0000950170-25-070452 | |
| us-gaap | FairValueDisclosureOffbalanceSheetRisksAmountAsset | Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset | USD | 0 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0000950170-25-107358 | |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 64,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 1.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 564,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 773,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 1.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 599,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 61,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 230,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 401,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 173,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 134,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 346,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 1.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 330,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.076 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -246,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | 10,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | -1.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -1.53M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 10.26M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039375 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 2.85M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | -459,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037172 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -3.76M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 117,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 1.93M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037172 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 343,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 173,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037172 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -998,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 5.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 1.39M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001564590-21-013876 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 323,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 481,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0000950170-25-107358 |
| us-gaap | IncreaseDecreaseInDueFromRelatedParties | Increase (Decrease) in Due from Related Parties | USD | 6,000 | 2019-01-01 | 2019-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022364 |
| us-gaap | IncreaseDecreaseInDueToRelatedPartiesCurrent | Increase (Decrease) in Due to Related Parties, Current | USD | -32,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030121 |
| us-gaap | IncreaseDecreaseInInsuranceSettlementsReceivable | Increase (Decrease) in Insurance Settlements Receivable | USD | 2.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 568,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -253,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 10,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001564590-20-052242 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 927,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | IncreaseDecreaseInSecurityDeposits | Increase (Decrease) in Security Deposits | USD | -19,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001564590-19-041122 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-061543 |
| us-gaap | InsuranceSettlementsReceivableCurrent | Insurance Settlements Receivable, Current | USD | 2.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | InterestBearingDepositsInBanks | Interest-bearing Deposits in Banks and Other Financial Institutions | USD | 300,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001660334-26-000014 | |
| us-gaap | InterestExpense | Interest Expense | USD | 4.69M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0000950170-24-096669 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 609,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | InterestExpenseRelatedParty | Interest Expense, Related Party | USD | 2,000 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006800 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 64,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006118 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 1.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 2.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 924,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 772,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 357,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 369,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 612,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001564590-21-013876 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three | USD | 58,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001564590-19-041122 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two | USD | 58,000 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022364 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months | USD | 139,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 246,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 360,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001564590-21-013876 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 123,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 39,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | Liabilities | Liabilities | USD | 45.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 39.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 21.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 0 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LineOfCreditFacilityCommitmentFeeAmount | Line of Credit Facility, Commitment Fee Amount | USD | 500.00M | 2024-06-26 | 2025 | Q1 | 10-Q | 2025-05-13 | 0000950170-25-070452 | |
| us-gaap | LitigationReserve | Estimated Litigation Liability | USD | 0 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001193125-18-240959 | |
| us-gaap | LitigationReserveCurrent | Estimated Litigation Liability, Current | USD | 4.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 800,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0000950170-24-120982 |
| us-gaap | LongTermDebt | Long-term Debt | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 15.28M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001660334-25-000006 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 4.38M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022364 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 8.75M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037172 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 8.75M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001660334-25-000006 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 15.00M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001660334-25-000006 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 3.89M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001660334-25-000006 | |
| us-gaap | LongTermLineOfCredit | Long-term Line of Credit, Noncurrent | USD | 11.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | LossContingencyAccrualCarryingValueCurrent | Loss Contingency, Accrual, Current | USD | 400,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0000950170-24-120982 | |
| us-gaap | LossContingencyNewClaimsFiledNumber | Loss Contingency, New Claims Filed, Number | claim | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022659 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 11.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -27.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -35.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -22.84M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001660334-26-000025 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -22.84M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001660334-26-000025 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 733,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 |
| us-gaap | NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 | Noncash or Part Noncash Acquisition, Value of Assets Acquired | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0000950170-25-107358 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -263,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 52.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -34.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 256,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 292,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0000950170-24-120982 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 330,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 330,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 68,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030121 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 304,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 236,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 333,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 136,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006800 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree | Operating Leases, Future Minimum Payments, Due in Rolling Year Three | USD | 58,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo | Operating Leases, Future Minimum Payments, Due in Rolling Year Two | USD | 139,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 58,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006800 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 139,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006800 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths | Operating Leases, Future Minimum Payments, Next Rolling Twelve Months | USD | 136,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 94,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-07 | 0001564590-21-025318 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.063 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 19,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 638,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022659 |
| us-gaap | OtherExpenses | Other Expenses | USD | 1,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001564590-21-013876 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 33,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 75,000 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-05 | 0001564590-20-036455 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -11,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 2.20M | 2023-02-01 | 2023-02-28 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-061543 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 156,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | PaymentsOfDebtRestructuringCosts | Payments of Debt Restructuring Costs | USD | 110,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 9,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022659 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | PrepaidExpenseCurrentAndNoncurrent | Prepaid Expense | USD | 700,000 | 2023-12-31 | 2024 | Q2 | 10-Q | 2024-08-14 | 0000950170-24-096669 | |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 86.25M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 39.60M | 2024-11-01 | 2024-11-30 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 35.00M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001564590-20-052242 |
| us-gaap | ProceedsFromLegalSettlements | Proceeds from Legal Settlements | USD | 800,000 | 2024-01-01 | 2024-12-31 | 2025 | Q1 | 10-Q | 2025-05-13 | 0000950170-25-070452 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 12.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022659 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | ProductionRelatedImpairmentsOrCharges | Production Related Impairments or Charges | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -9.54M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0000950170-25-107358 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 1.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 167,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 259,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-061543 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 17.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 262,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 300,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -360.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 16.14M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0000950170-25-107358 |
| us-gaap | Revenues | Revenues | USD | 17.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 306,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030121 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 49.10M | 2025-11-01 | 2025-11-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 30.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 300,000 | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0000950170-24-120982 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 125,000 | 2020-08-01 | 2020-08-31 | 2024 | Q3 | 10-Q | 2024-11-05 | 0000950170-24-120982 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.774 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.837 | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001193125-18-240959 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.706 | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001193125-18-240959 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.025 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.03 | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001193125-18-240959 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.026 | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001193125-18-240959 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations | shares | 4,071 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001564590-20-052242 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 178,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 27,677 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 128,780 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 5.98 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001660334-26-000014 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 3,479 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 2.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 11.37 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 403 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 537,263 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 26.74 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 36.16 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 14.46 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 8.5 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 7.45 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | SharePrice | Share Price | USD/shares | 6.52 | 2018-03-28 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001193125-18-240959 | |
| us-gaap | SharesIssued | Shares, Issued | shares | 2.58M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0000950170-24-120982 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 8.9 | 2024-11-30 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006118 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058208 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -5.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.1 | 2025-07-24 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001660334-26-000014 | |
| us-gaap | StockholdersEquityNoteSubscriptionsReceivable | Stockholders' Equity Note, Subscriptions Receivable | USD | 4,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058208 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 6.50M | 2025-11-01 | 2025-11-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensation | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | shares | 51,049 | 2020-07-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001564590-20-052242 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 4,250 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 36.50M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments | Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | USD | 36.50M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001564590-20-010832 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 49.12M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 155,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 15.51M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006800 | |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 10,514 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | TreasuryStockShares | Treasury Stock, Shares | shares | 105,144 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019169 | |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 | |
| us-gaap | UnbilledReceivablesCurrent | Unbilled Receivables, Current | USD | 46,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-13 | 0000950170-25-070452 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 1.50M | 2019-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0000950170-22-002685 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-11 | 0001660334-26-000008 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 21.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 27.52M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008242 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 21.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001660334-26-000030 |